DocGo Inc. DCGO
0.25 USD 0.00 (+0.57%)
At closeNov 6, 2026, 4:00 PM EST
0.25 0.00 +2.00%
After hours · Nov 6, 4:00 PM ET
0.2409 Day range 0.25
0.209 52-week range 1.17
- YTD
- -72.10%
- 1 year
- -77.10%
- Market cap
- 24.25M
- Revenue (ttm)
- 694.97M
- Profit margin
- 4.44%
- EPS (ttm)
- -1.94
- Shares out
- 101.53M
- Forward P/E
- 33.00
- YTD return
- -72.10%
- 1-year return
- -77.10%
- Volume
- 335.39K
- Avg volume
- 796.11K
- Open
- 0.2422
- Previous close
- 0.2436
- Day's range
- 0.2409 – 0.25
- 52-week range
- 0.209 – 1.17
- Beta
- 0.89
- Analysts
- Strong Buy
- Price target
- 6.22 (+2436.9%)
- Earnings date
- Aug 7, 2024
ALL -10.0564 (-97.63%)
Key statistics
- Enterprise value
- 427.47M
- PEG ratio
- 0.00
- Price / sales
- 0.63
- Price / book
- 1.35
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -25.70%
- Free cash flow
- 33.54M
- Total cash
- 89.46M
- Total debt
- 56.99M
- Return on equity
- 9.41%
- Short % of float
- 6.43%
- 50-day average
- 3.90
- 200-day average
- 3.52
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 6.22 +2436.9% upside
Now 0.245
- Target (low)
- 5.00
- Target (mean)
- 6.22
- Target (high)
- 8.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy1
- Buy6
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 7, 2024
Expected Aug 7, 2024. Consensus EPS estimate 0.21033.
Financials — quick view
DCGO Revenue — quarterly 73.42M
DCGO Net income — quarterly -15.82M
DCGO EPS — quarterly -0.16
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | 0.04 | 0.05 | +0.01 | +25.00% |
| Aug 7, 2024 | Jun 1, 2024 | 0.07 | — | — | — |
| Aug 7, 2024 | Jun 1, 2024 | 0.07 | 0.06 | -0.01 | -14.29% |
| May 8, 2024 | Mar 1, 2024 | 0.09 | — | — | — |
| May 8, 2024 | Mar 1, 2024 | 0.09 | 0.09 | 0.00 | 0.00% |
| Feb 28, 2024 | Dec 1, 2023 | 0.13 | 0.06 | -0.07 | -53.85% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 20, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Aug 20, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Aug 8, 2024 | Needham | reit | Buy | Buy |
| May 9, 2024 | BTIG | main | Buy | Buy |
| May 9, 2024 | Canaccord Genuity | main | Buy | Buy |
| May 9, 2024 | Needham | main | Buy | Buy |
About DocGo Inc.
DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- docgo.com
News
DocGo to Announce Third Quarter 2026 Results on Monday, November 9, 2026 
12 Health Care Stocks Moving In Tuesday's After-Market Session 
12 Health Care Stocks Moving In Tuesday's Intraday Session 
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Transcript: DocGo Q2 2026 Earnings Conference Call
- 12 Health Care Stocks Moving In Monday's After-Market Session
DocGo Narrows FY2026 Sales Guidance from $300.000M-$315.000M to $305.000M-$310.000M vs $306.281M Est 
DocGo Q2 EPS $(0.16) Misses $(0.06) Estimate, Sales $73.425M Miss $75.404M Estimate 
DocGo Likely To Report Narrower Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - 12 Health Care Stocks Moving In Wednesday's Intraday Session
Your note
Sign in to keep a note on DCGO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BIENSTOCK LEE | Chief Executive Officer | Stock Award(Grant) | Dec 11, 2024 | 1,606,260 |
| BURDIEK MICHAEL J | Director | Stock Award(Grant) | Dec 12, 2024 | 616,560 |
| KATZ STEVEN | Director | Purchase | Mar 14, 2024 | 69,534 |
| LEITE ETALVINA | Director | Sale | Dec 16, 2024 | 51,411 |
| ROSENBERG NORMAN | Chief Financial Officer | Stock Award(Grant) | Dec 11, 2024 | 718,283 |
| SMEDRA IRA | Director | Stock Award(Grant) | Dec 12, 2024 | 90,999 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 8.88% | 9,066,138 | 38.89M | Sep 29, 2024 |
| Blackrock Inc. | 7.06% | 7,202,891 | 30.90M | Sep 29, 2024 |
| Vanguard Group Inc | 4.90% | 4,999,921 | 21.45M | Sep 29, 2024 |
| Knott David M., Jr. | 3.01% | 3,070,850 | 13.17M | Sep 29, 2024 |
| WCM Investment Management, LLC | 2.57% | 2,626,971 | 11.27M | Sep 29, 2024 |
| Geode Capital Management, LLC | 2.21% | 2,252,516 | 9.66M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Russell 2000 ETF | 2.57% | 2,622,150 | 11.25M | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 2.51% | 2,560,873 | 10.99M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.36% | 1,391,846 | 5.97M | Sep 29, 2024 |
| JNL Series Trust-JNL/Multi Manager Small Cap Value Fund | 1.16% | 1,180,174 | 5.06M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 1.02% | 1,045,504 | 4.49M | Aug 30, 2024 |
| Nationwide WCM Focused Small Cap Fd | 0.78% | 799,300 | 3.43M | Jul 30, 2024 |